Outcomes of Children With BCR-ABL1–Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease Concurrently performed, our trial's primary ...

Researchers sought to determine whether venetoclax plus low-intensity chemotherapy would be effective in adult patients with ALL.

Incyte's stock valuation is on the higher side given looming patent expiries for Jakafi and Opzelura, and uncertain pipeline ...